Selank

Also known as: TP-7

CognitivePHASE 2

Clinical Status

Approved in Russia — not FDA approved.

Mechanism of Action

Modulates BDNF expression, influences serotonin and dopamine metabolism, and has effects on the GABAergic system. Also has immunomodulatory properties.

Dosing Defaults

Dose

250-500 mcg

Frequency

2-3x daily

Administration

Intranasal spray or subcutaneous injection

Timing

Morning or as needed for anxiety

Food

with or without

Duration

14-21 days

Dose range: 200-750 mcg per dose

Acute anxiolytic effects — use as needed or on a scheduled basis.

Side Effects

•Nasal irritation (spray)
•Headache
•Nausea
•Fatigue
•May enhance effects of benzodiazepines

Contraindications & Warnings

•Not medical advice

Compare

Compare Selank with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Selank dose.

Open Calculator

Related Cognitive Peptides

Semax

PHASE 2

Cognitive

Nootropic peptide approved in Russia. Enhances focus, memory, and neuroplasticity.

Dihexa

PRECLINICAL

Cognitive

Potent nootropic that promotes synapse formation. No human trials.

Noopept

PHASE 2

Cognitive

Dipeptide-derived nootropic for memory and neuroprotection. Approved in Russia.

P21

PRECLINICAL

Cognitive

Neurogenic peptide that promotes hippocampal neurogenesis in research models.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.